LUCKNOW: “Every third person in India is suffering from a liver-related disorder,” warned Prof. Shalimar, Professor, Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences (AIIMS), New Delhi.
Delivering the keynote address titled “Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Silent Killer” at CSIR-Central Drug Research Institute (CDRI), Lucknow, as part of the 84th CSIR Foundation Day and Translational Research Lecture Series, he highlighted the alarming spread of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), describing it as “the silent killer” that demands immediate national attention.
Prof. Shalimar, a leading hepatologist renowned for his research in fatty liver disease, liver failure, and Budd-Chiari syndrome, explained how MASLD, previously known as NAFLD, has become the most prevalent cause of chronic liver disease globally. He attributed its rapid growth in India to obesity, diabetes, and sedentary lifestyles, emphasizing that changing dietary habits and preventive care are crucial for reversing the trend.
Drawing insights from the Global Burden of Disease (GBD) 2021 study, he explained that India and other South Asian nations are projected to witness a sharp rise in obesity rates by 2050, directly contributing to an increasing incidence of metabolic liver disorders. He stressed on the need for early diagnosis, lifestyle modification, and multidisciplinary research to combat the rising epidemic of MASLD in the country.
The lecture also focused on the latest diagnostic and therapeutic advancements in liver disease management. Prof. Shalimar urged young scientists to engage in translational and clinical research aimed at developing new interventions and integrating India-specific epidemiological data with global therapeutic approaches.
Over 150 students from Maharishi University of Information Technology and Sri Sharda Group of Institutions joined CSIR-CDRI faculty and research scholars during the session. The attendees actively interacted with the speaker, gaining valuable insights into current trends in liver disease research and public health policy.
Presided over by Dr. Radha Rangarajan, Director of CSIR-CDRI, the session concluded with an engaging discussion and a vote of thanks. The event, part of CSIR-CDRI’s Translational Research Lecture Series, reaffirmed the institute’s commitment to advancing biomedical research and fostering awareness about critical public health challenges.
-
-
-
-
-
-
-
-
-
-
